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Abstract The gene encoding a transmembrane glycoprotein
LIG-1, of which the extracellular region was organized with the
leucine-rich repeats and immunoglobulin-like domains, was
disrupted in mice by gene targeting. LIG-1-deficient mice
developed a skin change on the tail and facial area after birth.
The affected skin was histologically reminiscent of the epidermis
in human common skin disease ‘psoriasis’. LIG-1 was expressed
in basal cells of the epidermis and outer root sheath cells of hair
follicles in mice. Interestingly, the LIG-1 expression was
apparently down-regulated in the psoriatic lesions, suggesting
that LIG-1 inversely correlates with proliferative ability of
epidermal keratinocytes. $ 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Psoriasis is one of the most common yet enigmatic human
skin diseases that a¡ect about 2% of the world’s population.
Psoriatic lesion is histologically characterized by epidermal
hyperplasia, neutrophil in£ux, and also accumulation of
T lymphocytes [1]. There has been long-standing debate about
whether psoriasis is primarily a disorder of the immune sys-
tem or of keratinocytes. Current thinking regarding the path-
ogenetic mechanism of psoriasis favors an immunological pro-
cess; human epidermal keratinocytes are responsive to growth
stimulatory signals released by activated T lymphocytes in the
lesion [2,3]. However, there is a great deal of evidence suggest-
ing that the keratinocytes in psoriasis have a genetic suscep-
tibility to external stimuli [4,5].
The LIG-1 gene was originally found in a screen for genes
up-regulated during neural di¡erentiation of mouse embry-
onal carcinoma cell line P19 [6]. Our previous study showed
that the mouse LIG-1 gene is expressed predominantly in the
brain, and is restricted to a small subset of glial cells in the
cerebellum and the olfactory bulb. Nucleotide sequence anal-
ysis of LIG-1 cDNA revealed that it encoded a type I trans-
membrane glycoprotein of which the extracellular region was
entirely composed of 15 leucine-rich repeats (LRRs) and three
immunoglobulin (Ig) domains. Although each kind of motif is
found in a wide range of proteins involved in cell adhesion
and speci¢c ligand binding [7], the combination of LRR and
Ig domains within a molecule is a fairly unique structural
feature; a similar domain organization is shared only by a
few membrane glycoproteins such as the vertebrate Trk family
of neurotrophin receptors [8] and Drosophila Kek1 [9], both of
which are thought to have neural-related functions. Therefore,
we inferred that LIG-1 might have roles mainly in neural-
related functions as a cell adhesion molecule and/or receptor,
and that the lack of LIG-1 might result in crucial defects in
the nervous system.
To clarify the physiological roles of LIG-1 in vivo, we gen-
erated LIG-1-de¢cient mice and analyzed their phenotype.
These analyses revealed novel ¢ndings: (1) LIG-1 is expressed
in the skin, and (2) LIG-1 inversely correlated with prolifer-
ative ability of epidermal keratinocytes.
2. Materials and methods
2.1. Generation of LIG-1-de¢cient mice
An approximately 20 kb genomic fragment containing six exons of
the LIG-1 gene was isolated from a mouse 129/Sv genomic library
(Stratagene). Since the complete exon/intron structure has not been
fully established, we refer to these exons as E1^E6 in the order of 5P^
3P orientation. Exon E1 was the ‘¢rst coding exon’ containing the
initiation codon for the ¢rst methionine of the LIG-1. In the targeting
vector pTVLIG1 (Fig. 1A), the short and long arms used for homol-
ogous recombination were the 0.75 kb PstI fragment containing the
upstream half of exon E1 and 6 kb EcoRI fragment located down-
stream, respectively. The neomycin-resistance (neo) and a herpes sim-
plex virus thymidine kinase (tk) gene cassettes were also placed. Lin-
earized pTVLIG1 was electroporated into R1 embryonic stem (ES)
cells [10], selected with G418 (200 Wg/ml), and the homologous re-
combinant clones were screened for by Southern blot genotyping.
Of 525 clones, two (A4 and C9) were correctly targeted and showed
normal karyotype (2n=40) (data not shown). These clones were used
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to produce chimeras by the modi¢ed aggregation method [11]. The
male chimeras were mated with C57BL/6 females (Nippon SLC Inc.),
and transmitted the mutation through the germ line. The generated
F1 progeny heterozygous for LIG-1 mutation (LIG-1þ=3) were nor-
mal, and were intercrossed to obtain homozygous mutant o¡spring
(LIG-13=3). The F2 littermates (wild-type, LIG-1þ=3 and LIG-13=3
mice) were used for all experiments. Since the results derived from the
A4 mutant ES cell clone were the same as from C9, all results de-
scribed in this report were from the A4 clone. All animals were main-
tained under speci¢c pathogen-free conditions, and experiments were
carried out with strict adherence to our institutional guidelines to
minimize distress in experimental animals.
2.2. Southern blot genotyping
Genomic DNA (10 Wg) was digested with EcoRI, separated through
0.7% agarose gels, transferred onto Hybond-Nþ nylon membranes
(Amersham), and hybridized with 32P-labeled DNA probes 1^4
(Fig. 1A).
2.3. Cloning and nucleotide sequencing of human LIG-1 cDNA
In the present study, human LIG-1 cDNA clones were isolated
from a human heart cDNA library (Stratagene) and subjected to nu-
cleotide sequence analyses. Human and mouse LIG-1 cDNA sequen-
ces have been submitted to the GenBank database with the accession
numbers AB050468 and D78572, respectively.
2.4. In situ hybridization
Cryostat or para⁄n-embedded sections were hybridized with 35S-
labeled antisense cRNA probes corresponding to the mouse LIG-1
cDNA (0.96 kb EcoRI-XhoI fragment) subcloned into pBluescript
SK(3) (Stratagene). Hybridization was performed according to the
standard protocol. After hybridization, hematoxylin^eosin staining
was performed to facilitate visualization of the histological structure
of the sections. Sense probes were always used as controls.
2.5. Immunochemical analysis
For preparation of anti-LIG-1 antibody, an oligo-peptide sequence
corresponding to amino acid residues 203^222 of mouse LIG-1
(TQLPVKAFKLPRLTQLDLNR; 20 amino acids) was chemically
synthesized, puri¢ed, and inoculated into rabbits. Although this pep-
tide sequence di¡ered from human LIG-1 at position 208 (K to R in
human), we con¢rmed that the anti-LIG-1 antibody was cross-reac-
tive with human LIG-1 (data not shown). The following antibodies
were also used: rabbit anti-Ki67, mouse anti-keratin 14 (K14) (No-
vocastra), rabbit anti-mouse keratin 6 (K6), keratin 10 (K10) (BAb-
CO), mouse anti-¢laggrin (Biomedical Technologies) and rat anti-
mouse L1-, K6-integrins (Chemicon International Inc.). Skin specimens
were ¢xed with cold acetone. After ¢xation, cryostat sections (5 Wm
thick) of skin were incubated with primary antibodies for 1 h at room
temperature, washed in phosphate-bu¡ered saline, and incubated with
£uorescein-conjugated donkey anti-rat IgG antibody, rhodamine-con-
jugated anti-rabbit IgG antibody or with £uorescein-conjugated don-
key anti-rabbit IgG antibody (Jackson ImmunoResearch Laborato-
ries). Cells isolated from the skin of tails and ears of newborn mice
were air-dried and incubated as described above. Slides were then
analyzed by £uorescence microscopy. Human specimens were ob-
tained from involved skin of psoriatic patients (n=5) and normal
volunteers (n=5) with their informed consent.
2.6. In vitro keratinocyte studies
Full-thickness skin of newborn mice was treated with 250 U/ml of
dispase overnight at 4‡C and the epidermis was peeled o¡ from the
dermis and trypsinized to prepare single cells. These cells were sus-
pended in KGM medium (Kyokuto) and plated on dishes for 10 min
(rapidly adherent cells: RACs), and then non-attached cells (late ad-
herent cells : LACs) were transferred to new dishes by washing. On
reverse transcriptase-polymerase chain reaction (RT-PCR) analysis,
the primers used for ampli¢cation of LIG-1 mRNA were as follows:
5P-TGAGGACTTGACGAATCTGC-3P (upstream) and 5P-ATGGA-
GTTGTTGCTGAGGTG-3P (downstream) to amplify a fragment
corresponding to nucleotides 723^1343 of the mouse LIG-1 cDNA
that includes exons 2^6. Each fraction of the cells was also immuno-
cytochemically analyzed using anti-LIG-1 antibody and anti-L1 or
K6-integrin antibody.
Fig. 1. Targeted disruption of LIG-1 gene results in skin abnormal-
ities. A: Structures of the wild-type allele, the targeting vector
pTVLIG1 and the targeted allele. Vertical closed boxes represent
exons E1^E6. Thick horizontal lines represent genomic sequences
used for homologous recombination. The neomycin-resistance (neo)
and the thymidine kinase (tk) gene cassettes, and probes 1^4 used
for Southern blot genotyping are also indicated. Restriction enzyme
sites; E, EcoRI; P, PstI. B: Southern blot genotyping of the wild-
type, LIG-1þ=3 and LIG-13=3 mice. The result was obtained with
probe 1. The 4.5 kb and 3.8 kb bands represent the wild-type allele
and the targeted allele, respectively. C: Northern blotting analysis
to determine LIG-1 gene expression in mice brain. D: Western blot-
ting analysis to determine LIG-1 protein expression in mice brain
with anti-LIG-1 antibody. E: Macroscopic phenotype of face and
tail. F: Histopathology of the a¡ected tail skin. Sections (4 Wm
thick) were stained with hematoxylin and eosin. Scale bar 100 Wm.
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3. Results and discussion
We generated LIG-1-de¢cient (LIG-13=3) mice by gene tar-
geting (Fig. 1A,B). A targeting vector was constructed to ter-
minate intrinsic translation at codon 55 by insertion of the
neomycin-resistance gene cassette. Northern and Western
blotting analyses con¢rmed that the targeted mutation com-
pletely abolished the expression of LIG-1 mRNA and protein
and that the truncated forms of LIG-1 were absent (Figs.
1C,D and 4C). Since the LIG-1 gene was expressed predom-
inantly in neural tissue and encoded a protein similar to other
neural-related cell adhesion- and/or receptor-like molecules,
we inferred that LIG-1 might have roles mainly in neural-
related functions and that the lack of LIG-1 might result in
crucial defects in the nervous system. Although Northern and
Western blotting analyses con¢rmed that the targeted muta-
tion completely abolished the expression of LIG-1 mRNA
and protein (Fig. 1C,D), LIG-13=3 mice were born at Men-
delian ratios, and were normal with respect to growth, behav-
ior and fertility. Morpho-histological screening revealed no
apparent defects in neural tissue (data not shown). It was
therefore assumed that LIG-1 might be either of minor im-
portance for overall development or other molecules in the
nervous system might compensate its de¢ciency.
Unexpectedly, at the postnatal age of 3 weeks to 4 months,
only the LIG-13=3 mice developed skin abnormalities on their
tail, facial area and ear, even though they were housed under
pathogen-free conditions. Grossly, tail skin of the LIG-13=3
mice showed a knot-like thickening with scales and the facial
area exhibited alopecia with scales and erosion (Fig. 1E). His-
tological examination of the a¡ected tail skin showed epider-
mal hyperplasia, hyperkeratosis with parakeratosis, neutrophil
in£ux and subcorneal pustules similar to ‘Munro’s microab-
scesses’ (Fig. 1F). All of these features were reminiscent of
those of the epidermis in psoriasis, while they lack in¢ltrations
of T lymphocytes and increased dermal capillarization [1]. In
the mildly a¡ected mice, they showed only the thickened epi-
dermis with no in£ammatory cell in¢ltration (data not
shown), suggesting that the lack of LIG-1 initially altered
the keratinocyte growth and di¡erentiation, and then subse-
quently recruited neutrophils into the dermis and epidermis.
No other area such as trunk and feet manifested such skin
change. The a¡ected areas of the LIG-13=3 mice were sites
that were not covered with thick hair and were exposed more
readily to non-speci¢c stimuli except for the feet where devel-
opment of the lesion is less common in psoriasis [1]. This
¢nding was consistent with the Kobner phenomenon [12], in
which in£ammation or wounding of psoriatic uninvolved skin
can result in development of psoriatic lesions, whereas similar
perturbation of normal skin does not result in such changes.
The psoriasiform epidermal changes were reversed by the
treatment of common anti-psoriatic drugs such as steroid
and vitamin D3 analogue ointments (Fig. 2).
To examine whether the LIG-13=3 epidermal keratinocytes
were altered in their proliferation and/or maturation, we im-
munohistochemically analyzed the a¡ected tail skin of LIG-
13=3 mice. Relatively few Ki67-positive cells were observed in
the epidermal basal cell layer of wild-type mice (Fig. 3A). In
contrast, almost all of the basal cells and a few suprabasal
cells were positive for Ki67 in the LIG-13=3 mouse lesion
(Fig. 3B), indicating that LIG-13=3 keratinocytes were highly
proliferative. K14 was expressed in basal cells of wild-type
mice, whereas it was also expressed in the suprabasal cells
in LIG-13=3 mouse lesions (Fig. 3C,D). K6, which is nor-
mally expressed in the epidermal basal cells in the tail skin,
was highly induced in the whole epidermis of LIG-13=3 mice
(Fig. 3E,F). K10, which was expressed in di¡erentiating ke-
Fig. 2. Reversal of psoriasiform epidermal change in LIG-13=3 mice
by anti-psoriatic drugs. Tail skin of LIG-1þ=3 mice was treated by
topical application of corticosteroid or vitamin D3 analogue for
2 weeks. These treatments gave the same results.
Fig. 3. Immunohistochemical analyses for keratinocyte proliferation
and di¡erentiation. Tail skin specimens were immunostained with
anti-Ki67 (A, B), anti-K14 (C, D), anti-K6 (E, F), anti-K10 (G, H),
and anti-¢laggrin antibodies (I, J). C, stratum corneum; E, epider-
mis; D, dermis. Scale bar 100 Wm.
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ratinocytes, was focally down-regulated in the LIG-13=3 epi-
dermis (Fig. 3G,H). Filaggrin, a late di¡erentiation marker of
keratinocytes, was found in the stratum corneum and granu-
losum in the wild-type skin, while it was reduced and limited
to the outer side of the thickened corneal layer in LIG-13=3
skin (Fig. 3I,J). These observations indicated that the lesional
LIG-13=3 keratinocytes were activated and in a hyperprolifer-
ative state with perturbed terminal di¡erentiation, as reported
in psoriasiform epidermis [13].
Since the phenotype of LIG-13=3 mice suggested that LIG-
1 is also expressed in the skin, we examined cutaneous LIG-1
expression. In situ hybridization analyses indicated that LIG-1
mRNA was abundantly expressed in the upper part of hair
follicles and in the basal cells of the epidermis in a lesser
extent (Fig. 4A). Immunohistochemical analysis revealed
that LIG-1 protein was found on the epidermal basal cells
as well as the hair follicle cells in the mouse-tail skin (Fig.
4B). The LIG-1-positive basal cells were clustered in patches.
The LIG-1 expression in the tail and facial skin was not di¡er-
ent as compared to the trunk skin, although trunk skin never
showed psoriasiform skin change (data not shown). We tried
to induce the similar phenotype by creating minor injuries on
the trunk skin of LIG-13=3 mice, but the mice did not devel-
op any psoriasiform skin changes. More continuous stimula-
tion might be necessary to induce such skin change in the
areas covered with thick hair.
Since undi¡erentiated basal keratinocytes strongly express
K6- and L1-integrins on their cell surface, these cells adhere
rapidly to the extracellular matrix [14,15]. Therefore, we di-
vided the mouse keratinocytes into two fractions of RACs
and LACs, and analyzed LIG-1 expression in the two frac-
tions (see Section 2). RT-PCR analysis showed that LIG-1
mRNA was abundantly expressed in RACs (Fig. 4C) but
was absent in LACs. LIG-1 mRNA was not detected in either
fraction in LIG-13=3 mouse. Immunocytochemical examina-
tion con¢rmed that all of the RACs expressed K6-integrin, and
a subpopulation of the K6-integrin-positive RACs showed
strong LIG-1 expression on their cell surface (Fig. 4D). This
cell population also expressed L1-integrins strongly (data not
shown). These results and the strong expression of LIG-1
mRNA in the bulge area of the hair follicles may suggest
the strong expression of LIG-1 in the undi¡erentiated kera-
tinocyte stem cells [16]. Further studies are required to de¢ne
the characteristics of LIG-1 strong positive keratinocytes.
The LIG-13=3 mouse phenotype suggested that the loss of
LIG-1 might trigger and/or in£uence the development of pso-
riasiform epidermal hyperplasia. Therefore, we compared the
LIG-1 expression level between the psoriatic skin and the
normal skin by immunohistochemistry. LIG-1 expression
was signi¢cantly down-regulated in the psoriatic epidermis
as compared with the normal skin (Fig. 5). Basal cells in
non-lesional skin of psoriatic patients showed no di¡erence
of LIG-1 expression with normal skin (data not shown).
These results indicate that LIG-1 may inversely correlate
with the proliferative ability of epidermal keratinocytes in
psoriasis.
While the mechanism directing the down-regulation of
LIG-1 in psoriasis remains unde¢ned, we hypothesized that
LIG-1 might negatively regulate the epidermal growth factor
(EGF) receptor-signaling pathway in the keratinocytes. Acti-
vation of the EGF receptor^ligand system in epidermal kera-
tinocytes is well characterized in psoriasis, and mice transgenic
for EGF receptor ligands such as transforming growth factor-
K and amphiregulin in epidermal keratinocytes show psoriatic
phenotypes similar to that in LIG-13=3 mice [17,18]. Recently,
the Drosophila Kek1, a transmembrane protein with domain
organization similar to LIG-1, has been reported to act in a
feedback loop to negatively regulate the activity of EGF re-
ceptors through the extracellular domain [19]. We inferred
that LIG-1 may function as a vertebrate Kek1-like molecule
to suppress the growth of keratinocyte and that the cells
would be released from the inhibitory e¡ect of LIG-1 in the
psoriasiform epidermis.
Fig. 4. In vivo and in vitro LIG-1 expression in mouse skin.
A: LIG-1 mRNA expression in the mouse skin (arrowhead). Scale
bar 100 Wm. B: LIG-1 protein expression (arrowhead). C: RT-PCR
detection of LIG-1 gene expression in newborn mice keratinocytes
from wild-type and LIG-13=3 mice. Lane 1, molecular weight
marker; lanes 2 and 4, RACs; lanes 3 and 5, LACs. D: Immunocy-
tochemical detection of LIG-1 and K6-integrin on wild-type mouse
keratinocytes.
Fig. 5. LIG-1 expression in psoriatic skin. LIG-1 was strongly ex-
pressed in the epidermal basal cells and outer root sheath cells of
hair follicles in normal human skin, but was apparently decreased
in the psoriatic skin.
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